BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37642928)

  • 1. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.
    Sekizaki T; Kameda H; Nakamura A; Kuwabara S; Nomoto H; Cho KY; Ishi Y; Motegi H; Miyoshi H; Atsumi T
    Pituitary; 2023 Oct; 26(5):597-610. PubMed ID: 37642928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the ERK pathway for the treatment of Cushing's disease.
    Zhang D; Bergsneider M; Wang MB; Heaney AP
    Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
    Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.
    Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M
    Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.
    Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M
    Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
    Fukuoka H; Cooper O; Ben-Shlomo A; Mamelak A; Ren SG; Bruyette D; Melmed S
    J Clin Invest; 2011 Dec; 121(12):4712-21. PubMed ID: 22105169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tubastatin A on adrenocorticotropic hormone synthesis and proliferation of AtT-20 corticotroph tumor cells.
    Hagiwara R; Kageyama K; Iwasaki Y; Niioka K; Daimon M
    Endocr J; 2022 Sep; 69(9):1053-1060. PubMed ID: 35296577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin, an HSP90 Inhibitor, on Human ACTH-Secreting Adenomas.
    Pecori Giraldi F; Cassarino MF; Sesta A; Lasio G; Losa M
    Neuroendocrinology; 2023; 113(6):606-614. PubMed ID: 36791678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
    Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
    J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease.
    Zhang D; Damoiseaux R; Babayan L; Rivera-Meza EK; Yang Y; Bergsneider M; Wang MB; Yong WH; Kelly K; Heaney AP
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e232-e246. PubMed ID: 33000123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of trichostatin A on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT-20 cells.
    Nakada Y; Kageyama K; Sugiyama A; Desaki R; Takayasu S; Niioka K; Murasawa S; Ishigame N; Asari Y; Iwasaki Y; Daimon M
    Endocr J; 2015; 62(12):1083-90. PubMed ID: 26497760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.
    van der Pas R; Feelders RA; Gatto F; de Bruin C; Pereira AM; van Koetsveld PM; Sprij-Mooij DM; Waaijers AM; Dogan F; Schulz S; Kros JM; Lamberts SW; Hofland LJ
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1880-90. PubMed ID: 24081741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel somatostatin receptor ligand for human ACTH - and GH -secreting pituitary adenomas.
    Regazzo D; Avallone S; MacSweeney CP; Sergeev E; Howe D; Godwood A; Bennett KA; Brown AJH; Barnes M; Occhi G; Barbot M; Faggian D; Tropeano MP; Losa M; Lasio G; Scaroni C; Pecori Giraldi F
    Eur J Endocrinol; 2024 Jan; 190(1):K8-K16. PubMed ID: 38123488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas.
    Batista DL; Zhang X; Gejman R; Ansell PJ; Zhou Y; Johnson SA; Swearingen B; Hedley-Whyte ET; Stratakis CA; Klibanski A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4482-8. PubMed ID: 16940446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of histone deacetylase 1/2 in adrenocorticotropic hormone synthesis and proliferation of corticotroph tumor AtT-20 cells.
    Hagiwara R; Kageyama K; Niioka K; Takayasu S; Tasso M; Daimon M
    Peptides; 2021 Feb; 136():170441. PubMed ID: 33181265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Nuclear Translocation of E2F1 and Its Association in Cushing's Disease.
    Araki T; Wang J; Lawrence R; Kawakami Y
    Endocrinology; 2022 Aug; 163(8):. PubMed ID: 35678423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease.
    Du L; Bergsneider M; Mirsadraei L; Young SH; Jonker JW; Downes M; Yong WH; Evans RM; Heaney AP
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8555-60. PubMed ID: 23653479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.
    Pereda MP; Lohrer P; Kovalovsky D; Perez Castro C; Goldberg V; Losa M; Chervín A; Berner S; Molina H; Stalla GK; Renner U; Arzt E
    Exp Clin Endocrinol Diabetes; 2000; 108(3):202-7. PubMed ID: 10926317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.